A single dose of penicillin works just as well to cure early syphilis as the three-injection regimen now used by many doctors, a new clinical trial says. Second and third doses of benzathine penicillin G (BPG) don’t provide any additional benefit in treating early-stage syphilis, researchers reported in the New England Journal of Medicine. “Benzathine… read on > read on >
Some parents avoid giving their kids fruit juice, for fear that it might rot their teeth. But the bad effects of juice on a child’s oral health could be short-lived, thanks to the remarkable properties of saliva, according to a new study. Saliva protects teeth and gums from bacteria by creating a slippery film on… read on > read on >
Recent years have seen a steady rise in nicotine pouch exposures read on >
Parents of college students headed back to campus might have some fundamental misunderstandings regarding their young adult’s mental health challenges, a new report said. About 1 in 5 college students reported that their mental health had declined since high school, according to the 2025 College Student and Graduate Behavioral Health Report issued by UnitedHealthcare. In… read on > read on >
The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk. In a study of more than 21,000 patients with obesity and heart disease but no diabetes, those taking Wegovy — which contains the active ingredient semaglutide — saw… read on > read on >
Many people with suicidal thoughts are turning to artificial intelligence (AI) chatbots for comfort and advice, and these programs might not be completely up to the challenge, a new study says. Chatbots respond appropriately when asked questions that reflect a very low or very high risk of suicide, providing factual answers or refusing to answer… read on > read on >
The diabetes drug metformin has been a mystery for more than six decades. The most prescribed diabetes med in the world, metformin is very effective in lowering blood sugar levels. But no one knows exactly how it works. But a new study sheds some light on metformin’s magic, potentially opening the door for development of… read on > read on >
A drug commonly prescribed to heart attack survivors may not benefit many of them, a new clinical trial has found. Beta-blockers do not appear to reduce the risk of death, a second heart attack or heart failure in people’s whose hearts weren’t damaged by the life-threatening event, results reveal. The findings are expected to overturn… read on > read on >
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing read on >
Disparities in education and access to insurance mean that heart failure hits Black American adults nearly 14 years earlier than it does white Americans, new research shows. Among Black patients, heart failure typically sets in at about 60 years of age, compared to 73.6 on average for white patients. The study, conducted by researchers at… read on > read on >
